Your selection
Innovation / 03.12.2024
Eckert & Ziegler: Changes in the Executive Board and Supervisory Board
The Supervisory Board of Eckert & Ziegler SE has appointed Dr. Gunnar Mann (57) as a new member of the Executive Board, effective 1 January 2025. He will assume operational responsibility for the Medical segment.
Dr. Mann who holds a doctorate in physics, joined Eckert & Ziegler in 1998 and initially started as head of development. He then served as managing director of various subsidiaries of Eckert & Ziegler SE and was appointed to the Group Executive Committee in 2011. Dr. Mann has proven expertise in the areas of radiation physics, process management and implementation of investment projects.
Jutta Ludwig, whose contract as a member of the Executive Board expires as planned on December 31, 2024 will join the Supervisory Board as a delegated member on January 1, 2025. Frank Perschmann will leave the Supervisory Board of Eckert & Ziegler SE at the end of the year.
“Dr. Mann knows Eckert & Ziegler like only few others and brings exactly the experience and expertise needed to expand production capacity in the growing medical segment and to set up facilities for new products,” explains Dr. Andreas Eckert, Chairman of the Supervisory Board of Eckert & Ziegler SE. “On behalf of the Supervisory Board, I would like to thank Mrs. Ludwig for her contribution in strengthening our position in China and I am pleased that her expertise will remain with the company. I would also like to express my thanks to Mr. Perschmann for his many years of work on the Supervisory Board and for his valuable input in the strategic development of the Group.”
About Eckert & Ziegler.
Eckert & Ziegler SE with more than 1.000 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Source: Press Release Eckert & Ziegler
Eckert & Ziegler: Changes in the Executive Board and Supervisory Board
Overview News
News Buch Berlin
Eckert & Ziegler with a Successful Start to the Year. 2026 Forecast Confirmed.
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) increased its sales in the first quarter of 2026 by 7% to €72.9 million compared with the same period last year.
more ...First Joint Career Day Brings Science and Industry Together
The Max Delbrück Center’s Career Day, held in cooperation with the operator of the Berlin-Buch Campus, offered young researchers insights into the working world of startups and biotech companies
more ...A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers have succeeded in developing a so-called nanobody that penetrates directly int...
more ...Events Buch Berlin
19.05.2026, 18:00
Campus-Kino: "Human Flow"
Der Künstler und Aktivist Ai Weiwei zeigt die Folgen der Flüchtlingskrise. Dazu reiste er mit Kameramännern in 23 Länder, sprach mit den Menschen und lernte ihre Schicksale kennen. Die filmische Reise...
more ...20.05.2026, 13:00
Herzliche Einladung zur CampusVital LOUNGE: "Wie das Geschlecht unsere Gesundheit prägt"
Ein Ausflug in die Welt des Stoffwechsels und geschlechtsspezifischer Unterschiede vorgestellt von Raphaela Fritsche.
more ...21.05.2026, 17:00
Open-Air-Sprechstunde der Bezirksbürgermeisterin Cordelia Koch am 21. Mai
Im Garten des StadtTeilZentrum des Frei-Zeit-Haus e.V. - Anmeldung erbeten
more ...
